20 ML idarubicin hydrochloride 1 MG/ML Injection — RxCUI 1791493
RxNorm drug concept · Semantic clinical drug
RxCUI 1791493
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
14 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1791493
Official name20 ML idarubicin hydrochloride 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asidarubicin HCl 20 MG per 20 ML Injection; IDArubicin HCl 20 MG in 20 ML Injection
FDA products mapped12
Package NDCs mapped14
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Idarubicin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Idarubicin is used to treat acute myeloid leukemia — a type of blood and bone marrow cancer that affects adults. It's always given alongside other anti-leukemia chemotherapy drugs,...
- What exactly is idarubicin being used to treat?
- No pills here — idarubicin is given through an IV by a nurse or doctor in a hospital or clinic setting. The infusion itself takes just 10 to 15 minutes, though you'll typically be...
- How will I receive this medication? Will I have to take pills at home?
🕸️ Concept Web — How 20 ML idarubicin hydrochloride 1 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
20 ML idarubicin hydrochloride 1 MG/ML Injection
RxCUI 1791493 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Idarubicin
5650IN -
Idarubicin hydrochloride
82124PIN
-
Idarubicin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Idamycin
224952BN
-
Idamycin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Idarubicin Injection
1791492SCDF -
Idarubicin hydrochloride Injection
2647541SCDFP -
Idarubicin Injectable Product
1156281SCDG -
Idarubicin hydrochloride Injectable Product
2662759SCDGP -
Idarubicin Injection [Idamycin]
1791494SBDF -
Idarubicin hydrochloride Injection [Idamycin]
2656800SBDFP -
Idamycin Injectable Product
1167125SBDG -
Injection
1649574DF - +1 more in this family
-
Idarubicin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Idarubicin hydrochloride 1 MG/ML
996151SCDC -
20 ML idarubicin hydrochloride 1 MG/ML Injection [Idamycin]
1791495SBD -
Idarubicin hydrochloride 1 MG/ML [Idamycin]
996153SBDC
-
Idarubicin hydrochloride 1 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Idarubicin hydrochloride 1 MG/ML
SCDC · 996151 -
Idarubicin Injection
SCDF · 1791492 -
Idarubicin hydrochloride Injection
SCDFP · 2647541 -
Idarubicin Injectable Product
SCDG · 1156281 -
Idarubicin hydrochloride Injectable Product
SCDGP · 2662759
Brand-Name Concepts
-
20 ML idarubicin hydrochloride 1 MG/ML Injection [Idamycin]
SBD · 1791495 -
Idarubicin hydrochloride 1 MG/ML [Idamycin]
SBDC · 996153 -
Idarubicin Injection [Idamycin]
SBDF · 1791494 -
Idarubicin hydrochloride Injection [Idamycin]
SBDFP · 2656800 -
Idamycin Injectable Product
SBDG · 1167125 -
Idamycin
BN · 224952
📦 FDA Products & Package NDCs
12 products · 14 package NDCs
14 package NDCs map to RxCUI 1791493 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00013-2576-05 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2576-05) / 5 mL in 1... | Idamycin PFS | Pfizer Laboratories Div Pfizer Inc | 2024-08-12 |
| 00013-2576-91 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2576-91) / 5 mL in 1... | Idamycin PFS | Pfizer Laboratories Div Pfizer Inc | 1997-02-17 |
| 00013-2586-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2586-10) / 10 mL in 1... | Idamycin PFS | Pfizer Laboratories Div Pfizer Inc | 2024-03-11 |
| 00013-2586-91 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2586-91) / 10 mL in 1... | Idamycin PFS | Pfizer Laboratories Div Pfizer Inc | 1997-02-17 |
| 00013-2596-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2596-20) / 20 mL in 1... | Idamycin PFS | Pfizer Laboratories Div Pfizer Inc | 2024-03-11 |
| 00143-9217-01 | 1 VIAL, GLASS in 1 BOX (0143-9217-01) / 5 mL in 1 VIAL, GLA... | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2017-01-30 |
| 00143-9218-01 | 1 VIAL, GLASS in 1 BOX (0143-9218-01) / 10 mL in 1 VIAL, GL... | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2017-01-30 |
| 00143-9219-01 | 1 VIAL, GLASS in 1 BOX (0143-9219-01) / 20 mL in 1 VIAL, GL... | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2017-01-30 |
| 00143-9306-01 | 1 VIAL, GLASS in 1 BOX (0143-9306-01) / 5 mL in 1 VIAL, GLA... | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2018-01-12 |
| 00143-9307-01 | 1 VIAL, GLASS in 1 BOX (0143-9307-01) / 10 mL in 1 VIAL, GL... | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2018-01-12 |
| 00143-9308-01 | 1 VIAL, GLASS in 1 BOX (0143-9308-01) / 20 mL in 1 VIAL, GL... | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2018-01-12 |
| 71288-0184-05 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-184-05) / 5 mL in 1... | Idarubicin Hydrochloride | Meitheal Pharmaceuticals Inc. | 2025-06-01 |
| 71288-0185-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-185-10) / 10 mL in 1... | Idarubicin Hydrochloride | Meitheal Pharmaceuticals Inc. | 2025-06-01 |
| 71288-0186-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-186-20) / 20 mL in 1... | Idarubicin Hydrochloride | Meitheal Pharmaceuticals Inc. | 2025-06-01 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (6) ·
Pfizer Laboratories Div Pfizer Inc (5) ·
Meitheal Pharmaceuticals Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9211 | Idarubicin hcl injection | 14 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.